Status:
UNKNOWN
MDCT vs. CBCT Guided Percutaneous Lung Nodule Biopsy: A Comparison of Pneumothorax Incidence and Associated Risk Factors
Lead Sponsor:
Northwell Health
Conditions:
Lung Diseases
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The goal of this study is to determine if cone beam computed tomography (CBCT) is a viable alternative imaging guidance modality for percutaneous transthoracic needle biopsy (PTNB) in a community hosp...
Detailed Description
Studies have shown that CBCT is a viable imaging modality for PTNB. Although MDCT-guidance remains the preferred procedural modality, research has shown that CBCT-guided biopsies can be carried out sa...
Eligibility Criteria
Inclusion
- Patients scheduled for lung biopsy at Mather Hospital's Department of Interventional Radiology.
- Patients ages from 18 years old to 90 years old.
Exclusion
- High risk patients will be excluded from the study.
- ( High risk - Any patient with severe emphysema with bullous emphysema on baseline Computed Tomography of the Chest, intended biopsy target/nodule adjacent to an airway or central vasculature, or less than 1 cm in size)
- Patients less than 18 years old
- Patients older than 90 years old
- patients who lack mental capacity for medical decision making
- Any patient requiring or requesting general anesthesia for the intended procedure
Key Trial Info
Start Date :
July 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 8 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05344430
Start Date
July 8 2021
End Date
July 8 2024
Last Update
May 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mather Hospital Northwell Health
Port Jefferson, New York, United States, 11777